why choose us

First received: December 06, 2022

Clinical Trial: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Study Status: Completed

Recruit Status: RECRUITING

Condition: Metabolic Syndrome

Study Type: INTERVENTIONAL


Official Title: Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction

Brief Summary: Coronary vascular dysfunction is one of the "final common pathways" for the impact of multiple cardiovascular risk factors.The investigators will conduct a randomized, double-blind placebo-controlled study in individuals with the metabolic syndrome and baseline coronary vascular dysfunction to evaluate the impact of vericiguat, a stimulator of soluble guanylyl cyclase, on coronary vascular function using non-invasive cardiac magnetic resonance imaging.

Read more